Abstract
BackgroundThe primary outcome measure for efficacy in clinical trials of urate lowering therapy (ULT) is frequently serum urate (SU), effectively acting as a surrogate for patient-centred outcomes (e.g. gout flares)....
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
